Numéro de téléphone : +880258611001
Site Web : https://www.beximcopharma.com
Adresse du bureau : 19 Dhanmondi R/A, Road No. 7, Dhaka 1205, Bangladesh
Adresse de l'usine : Beximco Pharma Industrial Park, Kathaldia, Auspara, Tongi, Gazipur-1711, Bangladesh
Région de l'entreprise : N/A
Descriptions : Beximco Pharmaceuticals Ltd is a major pharmaceutical manufacturer and exporter in Bangladesh, listed on the Dhaka Stock Exchange (DSE), Chittagong Stock Exchange (CSE), and AIM of the London Stock Exchange (LSE: BXP). Founded in 1976 and commencing operations in 1980 under licenses from international multinationals, the company grew into the flagship entity of the Beximco Group conglomerate. Operating state-of-the-art facilities certified by US FDA, EU GMP, TGA Australia, and Health Canada, Beximco Pharma was the first Bangladeshi pharmaceutical company to export finished formulation products to the United States. Producing over 500 branded generic products, Beximco Pharma exports medicines to more than 50 countries globally.
Nom du PDG : Iqbal Ahmed
Numéro de fax : +880258613888
Date d'enregistrement : 1976-03-10
Type d'entreprise : B2B,B2C
Pays : Bangladesh
Biens et services : Generic pharmaceutical formulations (tablets, capsules, IV fluids, metered-dose inhalers, nasal sprays, eye drops, suppositories), cardiovascular, respiratory, oncology, anti-diabetic, anti-infective, and gastrointestinal medications, Active Pharmaceutical Ingredients (APIs), and contract manufacturing services. Key brands include Napa (Paracetamol), D-Rise, and generic remdesivir/molnupiravir.
Code ISIC : C210 (Manufacture of pharmaceuticals, medicinal chemical and botanical products)
Sociétés affiliées ou filiales : N/A
